|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 8,608.00 JPY | -5.67% |
|
-2.19% | +4.43% |
| 02-06 | Japan's Nikkei rallies on earnings in unsteady trade before Sunday election | RE |
| 02-05 | Japanese drugmakers slump after Trump unveils discount drug website | RE |
| Capitalization | 14,166B 90.23B 76.38B 70B 66.3B 123B 8,175B 129B 814B 322B 3,935B 338B 331B | P/E ratio 2025 |
31.3x | P/E ratio 2026 * | 29.5x |
|---|---|---|---|---|---|
| Enterprise value | 13,270B 84.52B 71.55B 65.57B 62.11B 115B 7,657B 121B 762B 302B 3,686B 317B 310B | EV / Sales 2025 |
10.8x | EV / Sales 2026 * | 9.8x |
| Free-Float |
38.09% | Yield 2025 |
3.3% | Yield 2026 * | 1.62% |
Last Transcript: Chugai Pharmaceutical Co., Ltd.
| 1 day | -5.67% | ||
| 1 week | -2.19% | ||
| Current month | -2.19% | ||
| 1 month | +2.48% | ||
| 3 months | +15.27% | ||
| 6 months | +16.32% | ||
| Current year | +4.43% |
| 1 week | 8,608 |  | 9,441 |
| 1 month | 8,168 | | 9,441 |
| Current year | 8,168 | | 9,441 |
| 1 year | 5,942 | | 9,441 |
| 3 years | 3,203 | | 9,441 |
| 5 years | 3,191 | | 9,441 |
| 10 years | 1,003.33 | | 9,441 |
| Manager | Title | Age | Since |
|---|---|---|---|
Osamu Okuda
CEO | Chief Executive Officer | 62 | 2020-12-31 |
Iwaaki Taniguchi
DFI | Director of Finance/CFO | - | 2024-03-27 |
Junichi Nezu
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Motoo Ueno
BRD | Director/Board Member | 68 | 1993-02-28 |
Masayuki Oku
BRD | Director/Board Member | 81 | 2015-02-28 |
| Director/Board Member | 77 | 2017-02-28 |
| Name | Varia. Jan 1. | Weight | AuM | |
|---|---|---|---|---|
 | +5.19% | 6.57% | 29 M€ | |
| +7.91% | 1.87% | 69 M€ | |
| +5.41% | 1.59% | 4 M€ | |
| +7.78% | 1.53% | 73,790 M€ |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -5.67% | -2.19% | +24.36% | +151.26% | 90.23B | |
| +3.66% | +2.03% | +20.48% | +211.52% | 947B | |
| +0.93% | +5.61% | +56.73% | +46.87% | 578B | |
| +2.01% | +0.19% | +17.22% | +53.94% | 395B | |
| -0.64% | +1.63% | +23.32% | +25.27% | 367B | |
| +1.82% | +10.57% | +39.70% | +15.38% | 303B | |
| +0.89% | +3.71% | +21.59% | +33.23% | 298B | |
| +0.57% | +4.66% | +23.89% | +51.27% | 295B | |
| +4.49% | +12.41% | +30.93% | +57.51% | 207B | |
| +5.29% | -20.04% | -53.01% | -38.83% | 208B | |
| Average | +1.34% | +1.76% | +20.52% | +60.74% | 368.75B | |
| Weighted average by Cap. | +1.92% | +2.48% | +24.58% | +82.78% |
| 2025 | 2026 * | |
|---|---|---|
| Net sales | 1,247B 7.94B 6.72B 6.16B 5.84B 10.84B 719B 11.33B 71.6B 28.35B 346B 29.78B 29.17B | 1,341B 8.54B 7.23B 6.63B 6.27B 11.65B 774B 12.18B 76.99B 30.48B 372B 32.03B 31.37B |
| Net income | 428B 2.73B 2.31B 2.12B 2B 3.72B 247B 3.89B 24.58B 9.73B 119B 10.23B 10.02B | 481B 3.06B 2.59B 2.38B 2.25B 4.18B 277B 4.37B 27.61B 10.93B 134B 11.48B 11.25B |
| Net Debt | -896B -5.71B -4.83B -4.43B -4.19B -7.79B -517B -8.14B -51.46B -20.37B -249B -21.41B -20.97B | -1,031B -6.57B -5.56B -5.09B -4.82B -8.96B -595B -9.37B -59.2B -23.44B -286B -24.63B -24.12B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-02-06 | 8,608.00 ¥ | -5.67% | 3,777,900 |
| 26-02-05 | 9,125.00 ¥ | +4.86% | 5,012,600 |
| 26-02-04 | 8,702.00 ¥ | -1.46% | 2,410,200 |
| 26-02-03 | 8,831.00 ¥ | +0.33% | 2,561,400 |
| 26-02-02 | 8,802.00 ¥ | +0.01% | 2,649,300 |
Delayed Quote Japan Exchange, February 06, 2026 at 01:30 am
More quotes
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- 4519 Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition